NewsRoom

Archives: Search / 2017 / 2016 / 2015 / 2014 / 2013 / 2012 / 2011

201020092008

Mar 28, 2017
Live Webcast from New York on April 4th
Mar 14, 2017
Live Webcast from New York on March 21st
Feb 8, 2017
Company Begins Calendar Year with $55 Million in Cash
Dec 5, 2016
Phase 2 study results presented at American Society of Hematology Annual Meeting on Saturday, December 3, 2016
Nov 17, 2016
Live Webcast from San Diego on December 1st
Nov 9, 2016
Quarter Highlighted by Breakthrough Therapy Designation and Global Strategic Partnership for Pracinostat
Nov 7, 2016
Live Webcast from New York on November 15th
Sep 6, 2016
Company Now Well Positioned with Fully Funded, Phase III-Ready Asset, Emerging Pipeline and Strong Cash Balance
Aug 10, 2016
Live Webcast from New York on August 16th
Aug 8, 2016
MEI Pharma to receive $20 million in near-term cash payments, plus up to $444 million in potential milestone payments as well as royalties on future sales
Apr 20, 2016
Data Presented at AACR Show Excellent PK/PD, Potential for Improved Therapeutic Window
Apr 5, 2016
Live Webcast from New York on April 12th
 

rss